Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
9.73
+0.34 (3.62%)
At close: May 13, 2025, 4:00 PM
9.83
+0.10 (1.03%)
Pre-market: May 14, 2025, 7:00 AM EDT

Niagen Bioscience Market Cap

Niagen Bioscience has a market cap or net worth of $768.05 million as of May 14, 2025. Its market cap has increased by 200.84% in one year.

Market Cap
768.05M
Enterprise Value
716.11M
1-Year Change
200.84%
Ranking
Category
Stock Price
$9.73

Market Cap Chart

Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $768.05M, a decrease of -15.57%. That is a compound annual growth rate of -1.00%.

History

DateMarket Cap% Change
May 12, 2025739.60M82.53%
Dec 31, 2024405.20M277.28%
Dec 29, 2023107.40M-14.15%
Dec 30, 2022125.10M-51.02%
Dec 31, 2021255.40M-13.89%
Dec 31, 2020296.60M15.50%
Dec 31, 2019256.80M35.87%
Dec 31, 2018189.00M-33.29%
Dec 29, 2017283.30M125.74%
Dec 30, 2016125.50M-5.71%
Dec 31, 2015133.10M41.45%
Dec 31, 201494.10M-40.97%
Dec 31, 2013159.40M224.64%
Dec 31, 201249.10M19.76%
Dec 30, 201141.00M-49.88%
Dec 31, 201081.80M544.09%
Dec 31, 200912.70M-95.35%
Dec 31, 2008272.90M-70.00%
View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.55B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings